Cargando…
Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis
BACKGROUND: The overall response rate of immunotherapy in triple-negative breast cancer (TNBC) remains unsatisfactory. Accumulating evidence indicated that glucose metabolic reprogramming could modulate immunotherapy efficacy. However, transcriptomic evidence remains insufficient. METHODS: Genes...
Autores principales: | Xu, Tao, Liu, Jiahao, Xia, Yu, Wang, Zhi, Li, Xingrui, Gao, Qinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604452/ https://www.ncbi.nlm.nih.gov/pubmed/34134578 http://dx.doi.org/10.1080/07853890.2021.1937694 |
Ejemplares similares
-
Characterization of bovine FUT7 furthers understanding of FUT7 evolution in mammals
por: Laporte, Benoît, et al.
Publicado: (2012) -
LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8
por: Su, Changlei, et al.
Publicado: (2021) -
Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
por: Zhang, Yue, et al.
Publicado: (2023) -
Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8
Publicado: (2023) -
Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)